Crossmark

Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study

Crossref DOI link: https://doi.org/10.1038/s41366-018-0076-3

Published Online: 2018-05-01

Published Print: 2019-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Okamura, Takuro

Hashimoto, Yoshitaka

Hamaguchi, Masahide

Obora, Akihiro

Kojima, Takao

Fukui, Michiaki
License Information

Text and Data Mining valid from 2018-05-01
More Information

Article History

Received: 4 October 2017

Revised: 1 February 2018

Accepted: 13 February 2018

First Online: 1 May 2018

Compliance with ethical standards

:

: YH received grants from the Fuji Foundation for Protein Research, outside the submitted work. MF reports grants from AstraZeneca plc, grants from Astellas Pharma Inc., grants from Nippon Boehringer Ingelheim Co., Ltd., grants from Daiichi Sankyo Co., Ltd., grants from Eli Lilly Japan K.K., grants from Kyowa Hakko Kirin Company Ltd., grants from Kissei Pharmaceutical Co., Ltd., grants from MSD K.K., grants from Mitsubishi Tanabe Pharma Corporation, grants from Novo Nordisk Pharma Ltd., grants from Sanwa Kagaku Kenkyusho Co., Ltd., grants from Sanofi K.K., grants from Ono Pharmaceutical Co., Ltd., and grants from Takeda Pharmaceutical Co., Ltd., outside the submitted work. The remaining authors have no conflict of interest.